Summary for 2VWC
Entry DOI | 10.2210/pdb2vwc/pdb |
Related | 1A4H 1AH6 1AH8 1AM1 1AMW 1BGQ 1HK7 1US7 1USU 1USV 1ZW9 1ZWH 2AKP 2BRC 2BRE 2CG9 2CGE 2CGF 2IWS 2IWU 2IWX 2VW5 |
Descriptor | ATP-DEPENDENT MOLECULAR CHAPERONE HSP82, MACBECIN, GLYCEROL, ... (4 entities in total) |
Functional Keywords | chaperone, chaperone-complex, inhibitor, heat shock, atp-binding, stress response, multigene family, nucleotide-binding |
Biological source | SACCHAROMYCES CEREVISIAE (BAKER'S YEAST) |
Cellular location | Cytoplasm: P02829 |
Total number of polymer chains | 1 |
Total formula weight | 25427.04 |
Authors | Roe, S.M.,Prodromou, C.,Pearl, L.H. (deposition date: 2008-06-20, release date: 2008-07-01, Last modification date: 2023-12-13) |
Primary citation | Martin, C.J.,Gaisser, S.,Challis, I.R.,Carletti, I.,Wilkinson, B.,Gregory, M.,Prodromou, C.,Roe, S.M.,Pearl, L.H.,Boyd, S.M.,Zhang, M.Q. Molecular Characterisation of Macbecin as an Hsp90 Inhibitor J.Med.Chem., 51:2853-, 2008 Cited by PubMed Abstract: Macbecin compares favorably to geldanamycin as an Hsp90 inhibitor, being more soluble, stable, more potently inhibiting ATPase activity (IC50 = 2 microM) and binding with higher affinity (Kd = 0.24 microM). Structural studies reveal significant differences in their Hsp90 binding characteristics, and macbecin-induced tumor cell growth inhibition is accompanied by characteristic degradation of Hsp90 client proteins. Macbecin significantly reduced tumor growth rates (minimum T/C: 32%) in a DU145 murine xenograft. Macbecin thus represents an attractive lead for further optimization. PubMed: 18357975DOI: 10.1021/JM701558C PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.4 Å) |
Structure validation
Download full validation report
